BioCentury | May 28, 2020
Finance

May 27 Quick Takes: Atara raises $176M on back of MS data; plus Exscientia’s $60M C round, Geron, Silence, Arvelle, ViaCyte, Poxel, Accure, Tollys

...to about $50 million. Existing investors Bain Capital Life Sciences, TPG Capital, RA Capital Management, Sanderling...
BioCentury | Aug 7, 2019
Financial News

Glycomine looks toward clinic with Novo-led $33M round

...investors Asahi Kasei Pharma Corp. and Mission Bay Capital also participated, as did existing investors Sanderling...
...Pharmaceutical Inc. (NASDAQ:BMRN) and Raptor Pharmaceutical Corp. co-founder Chris Starr. Glycomine raised $12 million from Sanderling...
BioCentury | Nov 30, 2018
Financial News

ViaCyte attracts crossover investors for $80M series D

...the financing. New investors TPG Capital and RA Capital also participated, as did existing investor Sanderling...
BioCentury | Nov 29, 2018
Financial News

ViaCyte attracts crossover investors for $80M series D

...the financing. New investors TPG Capital and RA Capital also participated, as did existing investor Sanderling...
BioCentury | Oct 6, 2017
Financial News

SpecificiT completes seed financing

...Inc. (Montreal, Quebec) said it completed an undisclosed seed financing in late August led by Sanderling...
...allogeneic hematopoietic stem cell transplantation. SpecificiT also said it named Pierre Beauparlant, venture partner at Sanderling...
BioCentury | Jul 28, 2017
Financial News

PreciThera raises C$36M series A

...$28.6 million) on July 27 in an oversubscribed series A round led by Arix Bioscience. Sanderling...
BioCentury | Jul 27, 2017
Financial News

PreciThera raises C$36M in series A

...raised C$36 million ($28.6 million) in an oversubscribed series A round led by Arix Bioscience. Sanderling...
...NYSE:SNY). In May, PreciThera raised seed funding in the form of a consolidated loan from Sanderling...
BioCentury | May 26, 2017
Finance

Europe’s bellwether challenge

...Family Office, AstraZeneca plc, other undisclosed investors DalCor Pharma U.K. Ltd. (U.K.) Series B $100.0 Sanderling...
BioCentury | Dec 1, 2016
Emerging Company Profile

Safe arrest

...Paul Scherrer Institute Corporate partners: N/A Number of employees: 3 Funds raised: Undisclosed Investors: Sanderling...
BioCentury | Nov 18, 2016
Financial News

Glycomine completes venture financing

...Glycomine raised $12 million in a series A round led by Sanderling Ventures . Chiesi Ventures...
Items per page:
1 - 10 of 151
BioCentury | May 28, 2020
Finance

May 27 Quick Takes: Atara raises $176M on back of MS data; plus Exscientia’s $60M C round, Geron, Silence, Arvelle, ViaCyte, Poxel, Accure, Tollys

...to about $50 million. Existing investors Bain Capital Life Sciences, TPG Capital, RA Capital Management, Sanderling...
BioCentury | Aug 7, 2019
Financial News

Glycomine looks toward clinic with Novo-led $33M round

...investors Asahi Kasei Pharma Corp. and Mission Bay Capital also participated, as did existing investors Sanderling...
...Pharmaceutical Inc. (NASDAQ:BMRN) and Raptor Pharmaceutical Corp. co-founder Chris Starr. Glycomine raised $12 million from Sanderling...
BioCentury | Nov 30, 2018
Financial News

ViaCyte attracts crossover investors for $80M series D

...the financing. New investors TPG Capital and RA Capital also participated, as did existing investor Sanderling...
BioCentury | Nov 29, 2018
Financial News

ViaCyte attracts crossover investors for $80M series D

...the financing. New investors TPG Capital and RA Capital also participated, as did existing investor Sanderling...
BioCentury | Oct 6, 2017
Financial News

SpecificiT completes seed financing

...Inc. (Montreal, Quebec) said it completed an undisclosed seed financing in late August led by Sanderling...
...allogeneic hematopoietic stem cell transplantation. SpecificiT also said it named Pierre Beauparlant, venture partner at Sanderling...
BioCentury | Jul 28, 2017
Financial News

PreciThera raises C$36M series A

...$28.6 million) on July 27 in an oversubscribed series A round led by Arix Bioscience. Sanderling...
BioCentury | Jul 27, 2017
Financial News

PreciThera raises C$36M in series A

...raised C$36 million ($28.6 million) in an oversubscribed series A round led by Arix Bioscience. Sanderling...
...NYSE:SNY). In May, PreciThera raised seed funding in the form of a consolidated loan from Sanderling...
BioCentury | May 26, 2017
Finance

Europe’s bellwether challenge

...Family Office, AstraZeneca plc, other undisclosed investors DalCor Pharma U.K. Ltd. (U.K.) Series B $100.0 Sanderling...
BioCentury | Dec 1, 2016
Emerging Company Profile

Safe arrest

...Paul Scherrer Institute Corporate partners: N/A Number of employees: 3 Funds raised: Undisclosed Investors: Sanderling...
BioCentury | Nov 18, 2016
Financial News

Glycomine completes venture financing

...Glycomine raised $12 million in a series A round led by Sanderling Ventures . Chiesi Ventures...
Items per page:
1 - 10 of 151